Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 5Active not recruiting 3Terminated 1

Sponsor Class

OTHER 10INDUSTRY 5FED 2

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Plasma cell 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Neoplasms 1905Breast Neoplasms 1426Carcinoma, Non-Small-Cell Lung 1179Prostatic Neoplasms 740Colorectal Neoplasms 686Neoplasm Metastasis 624Multiple Myeloma 548Melanoma 529Ovarian Neoplasms 456Lung Neoplasms 447Lymphoma, Non-Hodgkin 385Recurrence 374Lymphoma 374Leukemia, Myeloid, Acute 370Pancreatic Neoplasms 358Carcinoma, Renal Cell 339Carcinoma, Hepatocellular 286Stomach Neoplasms 281Leukemia, Lymphocytic, Chronic, B-Cell 268Lymphoma, Follicular 254Head and Neck Neoplasms 246Glioblastoma 220Leukemia 215Small Cell Lung Carcinoma 183Lymphoma, Large B-Cell, Diffuse 183Squamous Cell Carcinoma of Head and Neck 181Urinary Bladder Neoplasms 175Carcinoma 175Uterine Cervical Neoplasms 174Advanced Solid Tumors 161

Interventions

pertuzumab 1pazopanib 1daratumumab 1Trastuzumab 1Surgical Procedures, Operative 1Sunitinib 1Sorafenib 1Radiotherapy 1Injections, Subcutaneous 1Ado-Trastuzumab Emtansine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Patient Preference × Clear all
NCT05415215 2026-02-10

ProHer

Hoffmann-La Roche

Phase 3 Completed
346 enrolled 20 charts
Breast

Breast Neoplasms, Patient Preference, Inflammatory Breast Neoplasms

NCT05284591 2024-10-01

MYLENE

iOMEDICO AG

Completed
96 enrolled
Plasma cell

Multiple Myeloma, Personal Satisfaction, Patient Satisfaction, Patient Preference

NCT05115006 2022-06-30

A Study of Adjuvant Melanoma Stakeholder Treatment Preferences

Bristol-Myers Squibb

Completed
294 enrolled
Dermatologic

Melanoma, Patient Preference

NCT02616692 2017-09-27

HCC Patient Preferences in Japan

Bayer

Completed
120 enrolled
Gastrointestinal

Liver Neoplasms, Patient Preference

NCT01064310 2017-04-17

PISCES

Novartis

Phase 3 Completed
169 enrolled 16 charts
Genitourinary

Carcinoma, Renal Cell, Neoplasms, Patient Preference

Data powered by HemOnc (CC BY 4.0) Colophon âš¡